These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17140371)

  • 1. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
    Lindberg RL; Kappos L
    Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.
    Hong J; Zang YC; Hutton G; Rivera VM; Zhang JZ
    J Neuroimmunol; 2004 Jul; 152(1-2):126-39. PubMed ID: 15223245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis.
    Achiron A; Gurevich M
    Autoimmun Rev; 2006 Oct; 5(8):517-22. PubMed ID: 17027885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics in multiple sclerosis--current state and future directions.
    Comabella M; Martin R
    J Neuroimmunol; 2007 Jul; 187(1-2):1-8. PubMed ID: 17400297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool.
    Centola M; Frank MB; Bolstad AI; Alex P; Szanto A; Zeher M; Hjelmervik TO; Jonsson R; Nakken B; Szegedi G; Szodoray P
    Scand J Immunol; 2006 Sep; 64(3):236-42. PubMed ID: 16918692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
    Lindberg RL; De Groot CJ; Certa U; Ravid R; Hoffmann F; Kappos L; Leppert D
    J Neuroimmunol; 2004 Jul; 152(1-2):154-67. PubMed ID: 15223248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.
    Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M
    Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD
    J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel interferon-beta-induced gene expression in peripheral blood cells.
    Rani MR; Shrock J; Appachi S; Rudick RA; Williams BR; Ransohoff RM
    J Leukoc Biol; 2007 Nov; 82(5):1353-60. PubMed ID: 17709400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
    Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
    Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA microarrays: identification of gene signatures and their application in clinical practice.
    Magic Z; Radulovic S; Brankovic-Magic M
    J BUON; 2007 Sep; 12 Suppl 1():S39-44. PubMed ID: 17935276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
    Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M
    J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA chips for gene expression analysis and their application in diagnostics].
    Galamb O; Molnár B; Tulassay Z
    Orv Hetil; 2003 Jan; 144(1):21-7. PubMed ID: 12635349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional analysis of targets in multiple sclerosis.
    Steinman L; Zamvil S
    Nat Rev Immunol; 2003 Jun; 3(6):483-92. PubMed ID: 12776208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using gene arrays in diagnosis of rejection.
    Khatri P; Sarwal MM
    Curr Opin Organ Transplant; 2009 Feb; 14(1):34-9. PubMed ID: 19337144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative, genome-scale transcriptional analysis of CHRF-288-11 and primary human megakaryocytic cell cultures provides novel insights into lineage-specific differentiation.
    Fuhrken PG; Chen C; Miller WM; Papoutsakis ET
    Exp Hematol; 2007 Mar; 35(3):476-489. PubMed ID: 17309828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
    Achiron A; Feldman A; Mandel M; Gurevich M
    Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.
    Goertsches RH; Zettl UK; Hecker M
    Pharmacogenomics; 2011 Mar; 12(3):423-32. PubMed ID: 21449680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
    Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
    Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.